Volition Webinar: Unraveling the web of NETs in sepsis

Volition Webinar: Unraveling the web of NETs in sepsis

VolitionRx — 7 videos in collection

More on this equity

VolitionRX is a multinational epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases, in both humans and other animals, including some cancers and diseases associated with NETosis such as sepsis and COVID-19.

In this webinar, intensive care specialist and haematology key opinion leader Dr Andrew Retter helps us understand the burden of sepsis and challenges in treatment and patient care, the connection between NETosis and sepsis, the future of tools and treatments, as well as the potential role of NETs in other disease areas, and the role of Volition’s diagnostics tools to address unmet need in the space.

Leading the panel and Q&A session is Soo Romanoff, Managing Director of Healthcare at Edison Group.


You may also be interested in these:

Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.